ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102. A total of 68 filers reported holding ONCOMED PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 30.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,000 | -88.9% | 500 | -87.5% | 0.00% | – |
| Q2 2018 | $9,000 | -64.0% | 4,000 | -50.0% | 0.00% | – |
| Q1 2018 | $25,000 | -24.2% | 8,000 | 0.0% | 0.00% | – |
| Q4 2017 | $33,000 | -8.3% | 8,000 | 0.0% | 0.00% | – |
| Q3 2017 | $36,000 | +28.6% | 8,000 | -2.0% | 0.00% | – |
| Q2 2017 | $28,000 | -76.9% | 8,160 | -38.0% | 0.00% | – |
| Q1 2017 | $121,000 | +9.0% | 13,160 | 0.0% | 0.00% | – |
| Q4 2016 | $111,000 | -26.5% | 13,160 | 0.0% | 0.00% | – |
| Q3 2016 | $151,000 | -6.8% | 13,160 | 0.0% | 0.00% | – |
| Q2 2016 | $162,000 | +21.8% | 13,160 | 0.0% | 0.00% | – |
| Q1 2016 | $133,000 | -57.9% | 13,160 | -6.0% | 0.00% | – |
| Q4 2015 | $316,000 | +12.1% | 14,000 | -17.6% | 0.00% | – |
| Q3 2015 | $282,000 | -26.4% | 17,000 | 0.0% | 0.00% | – |
| Q2 2015 | $383,000 | -26.1% | 17,000 | -15.4% | 0.00% | -100.0% |
| Q1 2015 | $518,000 | +57.0% | 20,095 | +32.3% | 0.00% | – |
| Q4 2014 | $330,000 | +58.7% | 15,191 | +38.1% | 0.00% | – |
| Q3 2014 | $208,000 | -32.0% | 11,000 | -16.2% | 0.00% | – |
| Q2 2014 | $306,000 | -17.3% | 13,120 | +19.3% | 0.00% | – |
| Q1 2014 | $370,000 | +78.7% | 11,000 | +57.1% | 0.00% | – |
| Q4 2013 | $207,000 | – | 7,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|